Announcement on Completion of Industrial and Commercial Filing
Filed with SSE · · 1 page · Chinese
Summary by 6ix AI
Beijing Foyou Pharma Co., Ltd. announced the completion of its industrial and commercial filing.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Beijing Foyou Pharma Co., Ltd. on 6ix
Earlier from Beijing Foyou Pharma
- Announcement on Approval Notice for Clinical Trials of Ketoprofen Gel Patch
- Announcement on the Election of Employee Directors and the Adjustment of Audit Committee Members
- Announcement on Obtainment of the Drug Registration Certificate for Ezetimibe and Atorvastatin Calcium Tablets (I)
- Announcement on Proposed Selection in the 11th National Centralized Drug Procurement
- Announcement on Convening the Q3 2025 Performance Briefing
Later from Beijing Foyou Pharma
- Announcement on Change of Investor Contact Number
- Announcement on Obtaining Drug Registration Certificate for Trazodone Hydrochloride Tablets
- Announcement on Change of the Signing Accountant
- Announcement on Obtaining Drug Registration Certificate for Bromhexine Hydrochloride Oral Solution
- Announcement on Selection of Products for Continuation Procurement Under National Procurement Scheme After Agreement Expiry
Follow Beijing Foyou Pharma into a list and get an email when it puts out news.
Follow Beijing Foyou Pharma